{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:12:06Z","timestamp":1759057926594},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian National Institute of Health, the Italian Ministry of Instruction University and Research (MIUR)"},{"name":"\u201cProgetto FILAS\u201d"},{"name":"AVIRALIA Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jviromet.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T16:02:11Z","timestamp":1371657731000},"page":"205-208","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Nucleotide polymorphisms in the 5\u2032-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype"],"prefix":"10.1016","volume":"193","author":[{"given":"Michela","family":"Pollicita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Cento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierpaolo","family":"Paba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Federico","family":"Perno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2013.06.002_bib0015","doi-asserted-by":"crossref","DOI":"10.3851\/IMP2529","article-title":"A boceprevir failure in a patient infected with HCV-genotype 1g: importance and limitations of virus genotyping prior to HCV PI-based therapy","author":"Cento","year":"2013","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2013.06.002_bib0020","doi-asserted-by":"crossref","first-page":"e8209","DOI":"10.1371\/journal.pone.0008209","article-title":"Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice","volume":"4","author":"Chevaliez","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2013.06.002_bib0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jviromet.2010.03.017","article-title":"A multicenter evaluation of the Abbott RealTime HCV Genotype II assay","volume":"167","author":"Ciotti","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2013.06.002_bib0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"55","author":"European Association for the Study of the Liver","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jviromet.2013.06.002_bib0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2011.01.011","article-title":"Hepatitis C virus resistance to protease inhibitors","volume":"55","author":"Halfon","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jviromet.2013.06.002_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350501000118","article-title":"Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes","volume":"10","author":"Hnatyszyn","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jviromet.2013.06.002_bib0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/omi.1.2000.5.129","article-title":"Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation","volume":"5","author":"Kato","year":"2000","journal-title":"Microb. Comp. Genomics"},{"key":"10.1016\/j.jviromet.2013.06.002_bib0050","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/hep.21781","article-title":"Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients","volume":"46","author":"Kieffer","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2013.06.002_bib0055","doi-asserted-by":"crossref","first-page":"e34372","DOI":"10.1371\/journal.pone.0034372","article-title":"Hepatitis C viral evolution in genotype 1 treatment-na\u00efve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials","volume":"7","author":"Kieffer","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2013.06.002_bib0060","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa0806104","article-title":"Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection","volume":"360","author":"McHutchison","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2013.06.002_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0166-0934(03)00070-3","article-title":"Determining hepatitis C genotype by analyzing the sequence of the NS5b region","volume":"109","author":"Meyer","year":"2003","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2013.06.002_bib0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0166-0934(03)00070-3","article-title":"Determining hepatitis C genotype by analizing the sequence of the NS5B region","volume":"109","author":"Sandres-Saune","year":"2003","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2013.06.002_bib0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2009.11.055","article-title":"Resistance to direct antiviral agents in patients with hepatitis C virus infection","volume":"138","author":"Sarrazin","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2013.06.002_bib0075","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2013.06.002_bib0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1517\/14656566.2012.653341","article-title":"Treatment failure with new hepatitis C drugs","volume":"13","author":"Soriano","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jviromet.2013.06.002_bib0085","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/JCM.02390-07","article-title":"Evaluation of versant hepatitis C virus genotype assay (LiPA) 2.0","volume":"46","author":"Verbeeck","year":"2008","journal-title":"J. Clin. Microbiol."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093413002152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093413002152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T13:11:35Z","timestamp":1688303495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093413002152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0166093413002152"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2013.06.002","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nucleotide polymorphisms in the 5\u2032-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2013.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}